Faraday Pharmaceuticals

Venture-backed company · Stage unknownfaradaypharma.com
Rounds on record
4
Latest round
Oct 24, 2022
Form D equity offering
Latest round size
$52.8M
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

3 additional investors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
4
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
4 rounds
  1. Oct 24, 2022
    Form D equity offering · $52.8M (form d sold)
    Arch Venture Partners via Steven Nmn Gillis
    Fact Form D · “Faraday Pharmaceuticals, Inc. Form D, first filed 2022-11-07”
  2. Aug 29, 2019
    Form D equity offering · $25.1M (form d sold)
    Arch Venture Partners via Steven Nmn Gillis
    Fact Form D · “Faraday Pharmaceuticals, Inc. Form D, first filed 2019-09-12”
  3. Mar 5, 2019
    Form D equity offering · $5.0M (form d sold)
    Arch Venture Partners via Steven Nmn Gillis
    Fact Form D · “Faraday Pharmaceuticals, Inc. Form D, first filed 2019-03-19”
  4. Jul 9, 2014
    Form D equity offering · $3.7M (form d sold)
    Fact Form D
Investors on record
5 edges
Ownership and outcomes
none on record
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
none on record
No lender position matched to this company.
People
0 officers, 0 directors
No officer or director on record.
Timeline
0 events
No dated event on record.
Evidence
4 observations
Every observation on this company
  • Listed on portfolio page: Sep 30, 2026 Fact no URL
  • Listed on portfolio page: Sep 16, 2026 Fact no URL
  • Listed on portfolio page: Sep 14, 2026 Fact no URL
  • Robots: disallowed Sep 17, 2026 Fact no URL